glp-1 gastric intestinal obstruction lawsuit in west virginia digestive blockage class action Potential Use of GLP- 1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? glp-1 digestive blockage lawyer in

Introduced in 2021, these injections address obesity as a chronic metabolic condition, not just a problem of willpower or temporary lifestyle changes

Always consult your physician or qualified healthcare provider regarding medical conditions, medications, and the exercise program that is appropriate for your individual needs.

This shift prioritizes short-term financial gains over long-term investments in new research and development (R&D), often at the expense of public health

Interestingly, the neural circuits responsible for the metabolic effects of GLP-1R agonism may be distinct from those mediating nausea or malaise (Huang et al., 2024), suggesting that future therapies could be tailored to preserve metabolic benefits while minimizing gastrointestinal side effects

On August 4, 2025, they filed 14 lawsuits in a single day against pharmacies and telehealth platforms